OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 24, 2020
The radiopharmaceutical CDMO is building a new cGMP facility in Springfield, NJ.
September 23, 2020
CMDO Piramal Pharma Solutions held a grand opening at a facility they acquired in Sellersville, PA.
September 09, 2020
The investment at its Madison, WI, facility will expand MilliporeSigma’s capacity for high-potent active pharmaceutical ingredient production and allow for continuous flow manufacturing of ADCs.
The company is investing $130 million to add Phase III through commercial-scale manufacturing suites to its gene therapy campus in Harmans, MD.
August 28, 2020
Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.
August 24, 2020
Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.
August 21, 2020
CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2.
August 14, 2020
Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.
August 13, 2020
The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.